Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMary B. Daly, Mary A. Dwyer, Tuya Pal et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 1.1k
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort ConsortiumNicolas Wentzensen, Lynne R. Wilkens, Lesley M. Butler et al.|Journal of Clinical Oncology|2016Cited by 517
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020Mary B. Daly, Susan Darlow, Robert Pilarski et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 507
Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal WomenDale P. Sandler, Minouk J. Schoemaker, Hazel B. Nichols et al.|JAMA Oncology|2018Cited by 367
Keap1–Nrf2 Signaling: A Target for Cancer Prevention by SulforaphaneThomas W. Kensler, Paul Talalay, Patricia A. Egner et al.|Topics in current chemistry|2012Cited by 354